Observational studyBMC medical informatics and decision making2025
Optimizing hypoglycaemia prediction in type 1 diabetes with Ensemble Machine Learning modeling.
Observational study in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Nanostructured electrode materials and flexible-substrate engineering for wearable multi-analyte biosensors in diabetes monitoring and personalized care: a comprehensive review.Journal of materials science. Materials in medicine · 2026Review
- Review
- Artificial intelligence in immunotherapy: revolutionizing diagnostic and therapeutic applications in cancer and autoimmune diseases.Clinical and experimental medicine · 2026Review
- A dynamic weighted ensemble learning framework for cardiovascular risk prediction in type 2 diabetes: a comparative study with SHAP-based interpretability.Scientific reports · 2025Article
- A deep learning framework with hybrid stacked sparse autoencoder for type 2 diabetes prediction.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundType 1 diabetes (T1D) is a chronic endocrine disorder characterized by high blood glucose levels, impacting millions of people globally. Its management requires intensive insulin therapy, frequent blood glucose monitoring, and lifestyle adjustments. The accurate prediction of the short-term course of glucose levels in the subcutaneous space in T1D people, as measured by a continuous glucose monitoring (CGM) system, is essential for improving glucose control by avoiding harmful hypoglycaemic and hyperglycaemic glucose swings, facilitating precise insulin management and individualized care and, in turn, minimizing long-term vascular complications.
methodsIn this study, we propose an ensemble univariate short-term predictive model of the subcutaneous glucose concentration in T1D targeting at improving its error in the hypoglycaemic region. As such, the underlying basis functions are selected to minimize the percentage of erroneous predictions (EP) in the hypoglycaemic region, with EP being evaluated with continuous glucose error grid analysis (CG-EGA). The dataset comprises 29 individuals with T1D, who were monitored for 2 to 4 weeks during the GlucoseML prospective observational clinical study.
resultsAmong six different basis models (i.e., linear regression (LR), automatic relevance determination (ARD), support vector regression (SVR), Gaussian process regression (GPR), eXtreme gradient boosting (XGBoost), and long short-term memory (LSTM)), XGBoost and SVR showed a dominant performance in the hypoglycaemic region and were selected as the constituent basis models of the ensemble model. The results indicate that the ensemble model significantly reduces the percentage of EP in the hypoglycaemic region for a 30 min prediction horizon to 19% as compared with its individual basis models (i.e., XGBoost and SVR), whilst its errors over the entire glucose range (hypoglycaemia, euglycaemia, and hyperglycaemia) are similar to those of the basis models.
conclusionsThe consideration of the performance of the basis functions in the hypoglycaemic region during the construction of the ensemble model contributes to enhancing their joint performance in that specific area. This could lead to more precise insulin management and a reduced risk of short-term hypoglycaemic fluctuations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.